Abstract
Vitamin D3 derivatives and retinoids can induce cell cycle arrest, differentiation and cell death in many cell lines. These compounds can act cooperatively in some of their functions and may be of potential use either individually or in combination in the treatment of breast cancer. The effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), all-trans retinoic acid (ATRA) and several analogues were evaluated on malignant phenotypic traits of breast cancer cell lines MCF-7, T-47D and MDA-MB-231. Both 1,25(OH)2D3 and ATRA caused a decrease in anchorage independent colony formation in MCF-7 and T-47D cells in a dose-dependent manner. The effects of 1,25(OH)2D3 10−10 and 10−9M were synergistic with ATRA 10−8M in T-47D cells but were antagonistic in both MCF-7 and in T-47D cells at most concentrations. Both 1,25(OH)2D3 and ATRA individually induced an accumulation of MCF-7 cells in the G1 phase of the cell cycle and an associated increase in p21WAF1/Cip1, p27Kipl and a dephosphorylation of Rb but the effects were not additive. Both compounds inhibited the invasive capacity of MDA-MB-231 cells. 1,25(OH)2D3 but not ATRA caused an increase in E-cadherin levels in MDA-MB-231 cells. These two functions were not additive. The compounds 1,25(OH)2D3, a noncalcemic analogue 1,25(OH)2-16-ene-23-yne-D3, ATRA, AGN195183, an RARα-specific agonist, and AGN190168 (tazarotene), an RARβγ-selective agonist, induced differentiation as determined by measurements of lipid droplet formation. The individual effects of 1,25(OH)2-16-ene-23-yne-D3 combined with ATRA or with tazarotene at 10−9M each were additive in MCF-7 and MDA-MB-231 cells on lipid formation. The data demonstrate that both 1,25(OH)2D3, ATRA, and selected analogues induce a more differentiated phenotype in breast cancer cells with additive effects that are function- and cell-specific.
Similar content being viewed by others
References
Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C: Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 73: 1341-1346, 1996
Carter CA, Pogribny M, Davidson A, Jackson CD, McGarrity LG, Morris, SM: Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (REL95-2) cells. Anticancer Res 16: 17-24, 1996
Barroga EF, Kadosawa T, Okumura M, Fujinaga T: Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines. Res Vet Sci 66: 231-36, 1999
Zhao XY, Ly LH, Peehi DM, Feldman D: Induction of androgen receptor by alpha, 25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells. Endocrinology 140: 1205-1212, 1999
Mathiasen IS, Colston KW, Binderup L: EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol 46: 365-37I, 1993
Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, Lausch E, Christov K, Roninson IB: A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 59: 3761-3767, 1999
Green S, Chambon P: Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4: 309-314, 1988
Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M: Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441-446, 1992
Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM: Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355: 446-449, 1992
Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG: RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251-1266, 1991
Schrader M, Bendik I, Becker-Andre M, Carlberg C: Interaction between retinoic acid and vitamin D signalling pathways. J Biol Chem 268: 17830-17836, 1993
Blutt SE, Allegretto EA, Pike JW, Weigel NL: 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergisticafly to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 138: 1491-1497, 1997
Campbell, Park, Uskokovic MR, Dawson MJ, Koeffler HP: Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid. Br J Cancer 79: 101-107, 1999
Defacque H, Sevilla C, Piquemal D, Rochette-Egly C, Marti J, Commes T: Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways. Leukemia 11: 221-227, 1997
James SY, Williams MA, Newland AC, Colston RW: Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol 32: 143-154, 1999
James SY, Williams MA, Kelsey SM, Newland AC, Colston KW: The role of vitamin D derivatives and retinoids in the differentiation of human leukemia cells. Biochem Pharm 54: 625-634, 1997
Koshizuka K, Kubota T, Said J, Koike M, Binderup L, Uskokovic M, Koeffler HP: Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. Anticancer Res 19: 519-524, 1999
Kang S, Li XY, Duell EA, Voorhees JJ: The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1, 25-dihydroxyvitamin D3 in human skin in vivo. J Investigative Dermatology 108: 513-518, 1997
Gibson DF, Bikle DD, Harris J: All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes. J Cell Phys 174: 1-8, 1998
Sorensen S, Solvsten H, Politi Y, Kragballe K: Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors. Skin Pharm 10: 144-152, 1997
Tsonis PA, Sargent MD, Del Rio-Tsonis K, Jung JC: 9-cis retinoic acid antagonizes the stimulatory effect of 1,25 dihydroxyvitamin D3 on chondrogenesis of chick limb bud mesenchymal cells: interactions of their receptors. Int J Developmental Biol 40: 1053-1059, 1996
Fogh K, Solvsten H, Johnke H, Kragballe K: All-trans retinoic acid inhibits binding of 1,25 dihydroxy-vitam in D3 to the vitamin D receptor in cultured human keratinocytes. Exp Dermatol 5: 24-27, 1996
Carlberg C, Saurat JH: Vitamin D-retinoid association: molecular basis and clinical applications. J Investigative Derm, Symposium proceedings, 1: 82-86, 1996
Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R: 1,25-Dihydroxyvitam in D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 60: 2040-2048, 2000.
Wieder R, Wang H, Shirke S, Wang Q, Menzel T, Feirt N, Jakubowski AA, Gabrilove JL: Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells. Growth Factors 15: 41-60, 1997
Ramirez-Zacarias JL, Castro-Munozledo, F, Kuri-Harcuch W: Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97: 493-497, 1992
Swinnen JV, Van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G: Androgens markedly stimulate the accumulation of neutral lipids in the prostatic adenocarcinoma cell line LNCaP. Endocrinology 137: 4468-4474, 1996
Lochter A, Srebrow A, Sympson CJ, Terracio N, Werb Z, Bissell MJ: Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J Biol Chem 272: 5007-5015, 1997
Wieder, R. Selection of Methods for Measuring Proliferation. In: Studzinski G, (ed) Cell Growth, Differentiation and Senescence: A Practical Approach. Oxford University Press, New York, NY, 1999, pp 1-32
Wang H, Rubin M, Fenig E, DeBlasio T, Mendelsohn J, Yahalom J, Wieder R: Basic FGF causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events. Cancer Res 57: 1750-1757, 1997
Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z, Yahalom J: Basic fibroblast growth factor confers growth inhibition andMitogen-activated Protein Kinase activation in human breast cancer cells. Clin Cancer Res 3: 135-142, 1997
Greco WR, Bravo G, Parsons JC: The search for synergy: a critical review from a response, surface perspective. Pharmacol Rev 47: 331-385, 1995
Jacob K, Wach F, Holzapfel U, Uein R, Lengyel E, Buettner R, Bosserhoff AK: In vitro modultion of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res 8: 211-219, 1998
Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP: 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prevent 6: 727-732, 1997
Korah R, Sysounthone V, Golowa Y, Wieder R: Basic fibroblast growth factor confers a more differentiated phenotype in MDA-MB-231 human breast cancer cells. Cancer Res. 60: 733-740, 2000
Seewaldt VL, Kim JH, Parker MB, Dietze FC, Srinivasan KV, CaIdwell LF: Dysregulated expression of cycl in D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated GO/G1-phase arrest and differentiation in vitro. Exp Cell Res 249: 70-85, 1999
Bhattacharjee M, Wientroub S, Vondcrhaar BK: Milk protein synthesis by mammary glands of vitamin D-deficient mice. Endocrinology 121: 865-874, 1987
Kiguchi K, Giometti C, Chubb CH, Fujiki H, Huberman E: Differentiation induction in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases I and 2A. Biochem Biophys Res Comm 189: 1261-1267, 1992
Bacus SS, Kiguchi K, Chin D, King CR, Huberman E: Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER-2 /neu antigen. Mol Carcinogen 3: 350-362, 1990
Danielsson C, Torma H, Vahlquist A, Carlberg C: Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis. Int J Cancer 81: 467-470, 1999
Elstner B, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP: 20-epi-Vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 55: 2822-2830, 1995
Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA: p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 493-504, 1995
Jing Y, Zhang J, Waxman S, Mira-y-Lopez R: Upregulation of cytokeratins 8 and 18 in human breast cancer T47D cells is retinoid-specific and retinoic acid receptor-dependent. Differentiation 60: 109-117, 1996
Liu M, lavarone A, Freedman LP: Transcriptional activation of the human p21WAF1/Cip1 gene by retinoic acid receptor; correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271: 31723-31728, 1996
Liu M, Lee M-H, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the cdk inhibitor p21 by vitam in D3 leads to induced differentiation of the myelomonocytic cell line U937. Genes Develop 10: 142-153, 1996
Lemon BD, Freedman LP: Selective effects of ligands on vitam in D3 receptor-and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol: 16: 1006-1016, 1996
Toma S, Isnardi L, Riccardi L, Bollag W: Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids. Anticancer Res 18: 935-942, 1998
Xu XC, Sneige N, Liu X, Nadagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R: Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res 57: 4992-4996, 1997
Paterson FC, Rudland PS: Identification of novel, stagespecific polypeptides associated with the differentiation of mammary epithelial stem cells to alveolar-like cells in culture. J Cell Phys 124: 525-538, 1985
Lee PP, Lee MT, Darcy KM, Shudo K, Ip MM: Modulation of normal mammary epithelial cell proliferation, morphogenesis, and functional differentiation by retinoids: a comparison of the retinobenzoic acid derivative RE80 with retinoic acid. Endocrinology 136: 1707-1717, 1995
Jimi S, Shono T, Tanaka M, Kono A, Yamada Y, Shudo K, Kuwano M: Effect of retinoic acid on morphological changes of human pancreatic cancer cells on collagen gels: a possible association with the metastatic potentials. Oncol Res 10: 7-14, 1998
Campbell MJ, Elstner E, Holden S, Uskokovic M, Koeffler HP: Inhibition of proliferation of prostate cancer cells by a 1 9-nor-hexafluoride vitamin D3 analogue involves the induction of p21WAF1, p27Kip1 and E-cadherin. J Mol Endocrin 19: 15-27, 1997
Benbow U, Schoenermark MP, Orndorff KA, Givan AL, Brinckerhoff CE: Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid. Clin Exp Metast 17: 231-238, 1999
Benbow U, Schoenermark MP, Mitchell TI, Rutter JL, Shimokawa K, Nagase H, Brinckerhoff CE: A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem 274: 25371-25378, 1999
Schoenermark MP, Mitchell TI, Rutter JL, Reczek PR, Brinckerhoff CE: Retinoid-mediated suppression of tumor invasion and matrix metalloproteinase synthesis. Ann New York Acad Sci 878: 466-486, 1999
Webber MM, Waghray A: Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Clin Cancer Res 1: 755-761, 1995
Vermeulen S, Van Marck V, Van Hoorde L, Van Roy F, Bracke M, Marcel M: Regulation of the invasion suppressor function of the cadherin/catenin complex. Pathol Res Pract 192: 694-707, 1996
Benbow U, Rutter JL, Lowrey CU, Briuckerhoff CE: Transcriptional repression of the human collagenase-1 (MMP-1 gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter. Br J Cancer 79: 221-228, 1999
Waghray A, Webber MM: Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells. Clin Cancer Res 1: 747-753, 1995
Vo UP, Lee MK, Crowe DL: Alpha2betal integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity. Int J Onc 13: 1127-1134, 1998
Pereda MP, Hopfner U, Pagotto U, Renner U, UhI E, Arzt E, Missale C, Stalla GK: Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion. Br J Cancer 81: 381-386, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, Q., Lee, D., Sysounthone, V. et al. 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res Treat 67, 157–168 (2001). https://doi.org/10.1023/A:1010643323268
Issue Date:
DOI: https://doi.org/10.1023/A:1010643323268